logo
CONTENT TYPES

Figure 1Loading Img

Structure Optimization of Gatastatin for the Development of γ-Tubulin-Specific Inhibitor

  • Kana Shintani
    Kana Shintani
    Graduate School, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8571, Japan
  • Haruna Ebisu
    Haruna Ebisu
    Graduate School, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8571, Japan
    More by Haruna Ebisu
  • Minagi Mukaiyama
    Minagi Mukaiyama
    Graduate School, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8571, Japan
  • Taisei Hatanaka
    Taisei Hatanaka
    Division of Applied Chemistry, Graduate School of Natural Science and Technology, Okayama University, 3-1-1 Tsushima-naka, Kita-ku, Okayama 700-8530, Japan
  • Takumi Chinen
    Takumi Chinen
    Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo 113-0033, Japan
  • Daisuke Takao
    Daisuke Takao
    Graduate School of Pharmaceutical Sciences, The University of Tokyo, Bunkyo, Tokyo 113-0033, Japan
  • Yoko Nagumo
    Yoko Nagumo
    Faculty of Life and Environmental Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8571, Japan
    More by Yoko Nagumo
  • Akira Sakakura
    Akira Sakakura
    Division of Applied Chemistry, Graduate School of Natural Science and Technology, Okayama University, 3-1-1 Tsushima-naka, Kita-ku, Okayama 700-8530, Japan
  • Ichiro Hayakawa*
    Ichiro Hayakawa
    Division of Applied Chemistry, Graduate School of Natural Science and Technology, Okayama University, 3-1-1 Tsushima-naka, Kita-ku, Okayama 700-8530, Japan
    *Phone +81 3 5317 9363. Email: [email protected] (Chemistry).
  • , and 
  • Takeo Usui*
    Takeo Usui
    Faculty of Life and Environmental Sciences,  Microbiology Research Center for Sustainability, , University of Tsukuba, 1-1-1 Tennodai, Tsukuba 305-8571, Japan
    *Phone +81 29 853 6629. Email: [email protected] (Biology).
    More by Takeo Usui
Cite this: ACS Med. Chem. Lett. 2020, 11, 6, 1125–1129
Publication Date (Web):March 30, 2020
https://doi.org/10.1021/acsmedchemlett.9b00526
Copyright © 2020 American Chemical Society
Article Views
499
Altmetric
-
Citations
LEARN ABOUT THESE METRICS

Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.

Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.

The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated.

Read OnlinePDF (6 MB)
Supporting Info (1)»

Abstract

Abstract Image

Gatastatin (O7-benzyl glaziovianin A) is a γ-tubulin-specific inhibitor that is used to investigate γ-tubulin function in cells. We have previously reported that the unsubstituted phenyl ring of the O7-benzyl group in gatastatin is important for γ-tubulin inhibition. To obtain further structural information regarding γ-tubulin inhibition, we synthesized several gatastatin derivatives containing a fixed O7-benzyl moiety. Modifications of the B-ring resulted in drastic decrease in cytotoxicity, abnormal spindle formation activity, and inhibition of microtubule (MT) nucleation. In contrast, various O6-alkylated gatastatin derivatives showed potent cytotoxicity, induced abnormal spindle formation, and inhibited MT nucleation. We had previously reported that O6-benzyl glaziovianin A is a potent α/β-tubulin inhibitor; thus, these new results suggest that the O6-position restricts affinity for α/β- and γ-tubulin. Considering that an O7-benzyl group increases specificity for γ-tubulin, more potent and specific γ-tubulin inhibitors can be generated through O6-modifications of gatastatin.

Supporting Information

ARTICLE SECTIONS
Jump To

The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsmedchemlett.9b00526.

  • Experimental details for synthesis and analysis of compounds 315; conditions for biological assays (PDF)

Terms & Conditions

Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: http://pubs.acs.org/page/copyright/permissions.html.

Cited By


This article is cited by 1 publications.

  1. Haruna Ebisu, Kana Shintani, Takumi Chinen, Yoko Nagumo, Shuya Shioda, Taisei Hatanaka, Akira Sakakura, Ichiro Hayakawa, Hideo Kigoshi, Takeo Usui. Dual Inhibition of γ-Tubulin and Plk1 Induces Mitotic Cell Death. Frontiers in Pharmacology 2021, 11 https://doi.org/10.3389/fphar.2020.620185

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

Pair your accounts.

Export articles to Mendeley

Get article recommendations from ACS based on references in your Mendeley library.

You’ve supercharged your research process with ACS and Mendeley!

STEP 1:
Click to create an ACS ID

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.

OOPS

You have to login with your ACS ID befor you can login with your Mendeley account.

MENDELEY PAIRING EXPIRED
Your Mendeley pairing has expired. Please reconnect

This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. Read the ACS privacy policy.

CONTINUE